Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delayTeresa Coelho, Cheng‐Yin Tan, Márcia Waddington‐Cruz et al.|Amyloid|2023Cited by 15
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOSJonas Wixner, Nitasha Sarswat, Angela Dispenzieri et al.|Cardiology and Therapy|2025Cited by 4